TipRanks
Go Ultimate55% OFF

Tiziana Life Sciences (TLSA) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Foralumab NasalAls, Als (Amyotrophic Lateral Sclerosis), Als - Amyotrophic Lateral SclerosisPhase IINot Yet RecruitingThe BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal ForalumabJun 30, 2026―
Foralumab NasalTolerability, SafetyPhase ICompletedSafety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human VolunteersMar 11, 2025―
Foralumab NasalMultiple System AtrophyPhase IIRecruitingA Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)Mar 06, 2025
Foralumab Tzls-401 100 ΜgNon-Active Secondary Progressive Multiple SclerosisPhase IIRecruitingNasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisFeb 12, 2025
ForalumabSecondary Progressive Multiple SclerosisPhase IIActive Not RecruitingA Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsFeb 02, 2024

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tiziana Life Sciences (US) (TLSA) have in its pipeline
Tiziana Life Sciences TLSA is currently developing the following drugs: Foralumab Nasal, Foralumab Tzls-401 100 Μg, Foralumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.